Concepedia

Tomas Rouse

TR

Statistics

Publications

4

Citations

82

H-Index

4

Active since

2018

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (Sweden)

AstraZeneca (Australia)

Monash University

Monash Health

Tomas Rouse is an author at AstraZeneca (United States) specializing in autoimmunity, autoimmune disease, and medicine.

Top concepts

Publications per year

2018–2022

4

Publications

4

Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers

Raj Tummala, Tomas Rouse, Anna Berglind et al. · Lupus Science & Medicine · 2018 · 33 citations · Full text

Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Ian N Bruce, Alireza Nami, Erik Schwetje et al. · The Lancet Rheumatology · 2020 · 24 citations

, , +13

Relationship of anifrolumab pharmacokinetics with efficacy and safety in patients with systemic lupus erythematosus

Yen Lin Chia, Jianchun Zhang, Raj Tummala et al. · Lara D. Veeken · 2021 · 13 citations · Full text

Relationship Between Anifrolumab Pharmacokinetics, Pharmacodynamics, and Efficacy in Patients With Moderate to Severe Systemic Lupus Erythematosus

Yen Lin Chia, Raj Tummala, Tu H. et al. · The Journal of Clinical Pharmacology · 2022 · 12 citations · Full text

1–4 of 4